Management Report

4. Corporate Structure

Bayer AG, headquartered in Leverkusen, Germany, is the strategic management holding company for the Bayer Group. Business operations are conducted by the HealthCare, CropScience and Material­Science subgroups.

Sales in the First Half of 2015

Our subgroups are supported by the Business Services, Technology Services and Currenta service companies, which are reported in the reconciliation as “All Other Segments” along with “Corporate Center and Consolidation.”

Key Data by Subgroup and Segment    [Table 3]
  Sales EBIT EBITDA before special items1
  2nd
Quarter
2014
2nd
Quarter
2015
2nd
Quarter
2014
2nd
Quarter
2015
2nd
Quarter
2014
2nd
Quarter
2015
  € million € million € million € million € million € million
HealthCare 4,615 5,908 927 1,068 1,314 1,675
Pharmaceuticals 2,960 3,492 656 706 927 1,077
Consumer Health 1,655 2,416 271 362 387 598
CropScience 2,470 2,723 470 571 615 733
MaterialScience 2,864 3,185 109 278 270 506
Reconciliation 279 274 (71) (84) (23) (15)
Group 10,228 12,090 1,435 1,833 2,176 2,899
 
  1st Half
2014
1st Half
2015
1st Half
2014
1st Half
2015
1st Half
2014
1st Half
2015
HealthCare 8,984 11,412 1,858 2,054 2,580 3,231
Pharmaceuticals 5,742 6,692 1,297 1,397 1,800 2,065
Consumer Health 3,242 4,720 561 657 780 1,166
CropScience 5,370 5,815 1,458 1,445 1,713 1,773
MaterialScience 5,667 6,199 328 497 636 930
Reconciliation 559 543 (144) (219) (50) (94)
Group 20,580 23,969 3,500 3,777 4,879 5,840
2014 figures restated
1 For definition see Chapter 6 “Calculation of EBIT(DA) Before Special Items.”

Changes in corporate structure

Following the signing of the divestiture agreement in June 2015, the Diabetes Care business is recognized under discontinued operations. The Medical Care Division now only comprises the business with contrast agents and medical devices. All data and prior-year figures are restated accordingly unless otherwise indicated.

Last updated: July 29, 2015  Copyright © Bayer AG
http://www.quarterly-report-2015-q2.bayer.com